Metraipolis › archive › dc_bdcb9e98f5a4

Upadacitinib in refractory ulcerative colitis patients with high thromboembolic risk: two case reports — Europe PMC PMID:41853288

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41853288
DOI
10.3389/fimmu.2026.1716943
License (as archived)
solo-consultazione
Archived
2026-11-05T03:55:54.302Z
SHA-256 of the archived text
c32528427fd177dbfe4e1619af32da3089f6e13ed4efe58fb5b18d6cee42ba7c
Stable URL of this page
https://metraipolis.com/documento/dc_bdcb9e98f5a4

How to cite

Upadacitinib in refractory ulcerative colitis patients with high thromboembolic risk: two case reports — Europe PMC PMID:41853288 — Europe PMC (en), https://europepmc.org/article/MED/41853288 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bdcb9e98f5a4 (Metraipolis archive dc_bdcb9e98f5a4, sha256 c32528427fd177dbfe4e1619af32da3089f6e13ed4efe58fb5b18d6cee42ba7c)
BibTeX
@misc{dcbdcb9e98f5a4,
  title = {Upadacitinib in refractory ulcerative colitis patients with high thromboembolic risk: two case reports — Europe PMC PMID:41853288},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41853288},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bdcb9e98f5a4; sha256 c32528427fd177dbfe4e1619af32da3089f6e13ed4efe58fb5b18d6cee42ba7c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41853288. Agents can read the archived copy with the MCP tool read_document.